Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.
about
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort studyHIV & immune reconstitution inflammatory syndrome (IRIS)Tuberculosis: From an incurable scourge to a curable disease - journey over a millenniumNeurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapyCNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogensImmune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs.Immunoregulation in Fungal DiseasesIntegrated therapy for HIV and cryptococcosisImpact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse casesIncidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort studyDiscordance in CD4+T-cell levels and viral loads with co-occurrence of elevated peripheral TNF-α and IL-4 in newly diagnosed HIV-TB co-infected casesTuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settingsThoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings.Immune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy.Immune reconstitution inflammatory syndrome of the brain: case illustrations of a challenging entity.Risk factors for mortality from primary cryptococcosis in patients with HIV.PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids.Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational DatabaseClinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era.Neurologic presentations of AIDS.Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy.Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infectionGuidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerImmunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand.Inpatient health services utilization among HIV-infected adult patients in care 2002-2007.Multilocus sequence typing of serially collected isolates of Cryptococcus from HIV-infected patients in South Africa.Immune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature ReviewTB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasoneImmune reconstitution inflammatory syndrome presenting as chylothorax in a patient with HIV and Mycobacterium tuberculosis coinfection: a case report.A non-synonymous polymorphism in IL-23R Gene (rs1884444) is associated with reduced risk to schistosomiasis-associated Immune Reconstitution Inflammatory Syndrome in a Kenyan population.Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique.Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort studyConfusion in the Study of Immune Reconstitution Inflammatory Syndrome.d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.
P2860
Q21144623-EC6BF75E-E482-40C2-A8A2-2ACD621E5477Q26852805-32480F65-4A02-4741-BD02-C73E4516520EQ26865560-3CAB7563-75FF-418A-951B-555D2E91C305Q27000422-9C40F59F-B298-4AC6-985B-A6B7EDCFA24EQ27011721-D2D3C7CA-7BE2-412F-95DA-D739C9F2D533Q27687272-4F763977-C6D9-4F41-86BC-CF869F317090Q28074776-D0E1B8B6-DF99-4A66-8088-092937FB0CBAQ28077707-5DDAEB6F-417D-446B-87A2-29C0C4CC4BA4Q28469286-90BFAA1D-9ADE-4DD5-8B2D-49F40508B72FQ28477511-97563743-8B7F-4802-A4B0-527915811B53Q28478173-B0E356EA-B27C-4B5D-8B27-CFEC84E0376BQ28535056-62B2BD7F-DE1C-42CA-9082-66347FC44457Q28749315-C5EF1935-4C0F-41D3-BA22-21F9D37BC4D9Q30364647-64E0DB98-ADA3-4CFA-8B5F-E3971BA0B1E4Q30969485-FFE46514-0650-4AE1-8180-A376C2C2F98EQ31164668-E7AB0192-A008-4F73-BF3F-7589B69ABA5BQ33157255-B950DAA4-2995-4ABA-A102-7608A11B25B7Q33398308-F8F6B88F-BD74-4265-AC45-194E574B496BQ33433188-1643133D-DDA6-49CD-B2AB-3AB05F6AA9C7Q33442216-492BBFB4-D23A-43BB-8EAE-8D74B6AB128FQ33484755-BB823B59-FD16-471C-82A2-794F236ED210Q33590337-3ECE13A2-624A-4542-B3B3-616D1DE4F40DQ33605245-03917D43-AE31-4E7B-A010-5384381CBBF7Q33628799-68134686-A86C-4D28-840B-BB991618EE0BQ33650105-31A7F74B-5DA6-44C7-9424-67983544F221Q33686938-0B4986CA-D22E-445E-93D7-4B0F3228A398Q33699011-3116AF9B-04E2-4C22-A03D-282DB4C02C5BQ33703545-6B057707-972F-4243-B212-82CEF84BE16EQ33715659-34476D07-53A8-4CE7-BFE6-220A4F0DD9E1Q33732480-CB43BAA6-046A-4D87-A505-DCC329920662Q33741113-48325673-BA32-46A3-A862-E5CB7C0052E6Q33756118-402CADF5-BBC6-4595-B003-23240CE54FBEQ33807615-465AB62A-27E3-47B9-8162-4BD18E127AAAQ33815631-88FDEE36-3027-486C-B1BB-F15BC258CB52Q33840983-99879661-2207-4BC2-8940-3DFBE4D08BFEQ33893285-70A0BD5E-0454-4F2A-8F73-DE29DCA043C3Q33894801-A4CC1080-8750-4F2C-9A93-775943E646C9Q33920429-40043B53-5431-45D2-825E-45F29619548FQ33941296-8DF4EDA0-8E63-436F-9B65-207819C7B7DBQ34020746-EE75230E-E8D7-471E-8E2A-B466295C7EB2
P2860
Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Incidence and risk factors for ...... active antiretroviral therapy.
@ast
Incidence and risk factors for ...... active antiretroviral therapy.
@en
type
label
Incidence and risk factors for ...... active antiretroviral therapy.
@ast
Incidence and risk factors for ...... active antiretroviral therapy.
@en
prefLabel
Incidence and risk factors for ...... active antiretroviral therapy.
@ast
Incidence and risk factors for ...... active antiretroviral therapy.
@en
P2093
P1433
P1476
Incidence and risk factors for ...... active antiretroviral therapy.
@en
P2093
A Clinton White
Edward A Graviss
Fehmida Visnegarwala
Jorge Darcourt
Richard J Hamill
Samuel A Shelburne
Thomas P Giordano
P304
P356
10.1097/01.AIDS.0000161769.06158.8A
P407
P577
2005-03-01T00:00:00Z